Connect with us


3 Royal Gold Marijuana Stocks to Buy for 2019: InvestorPlace’s MoneyWire Report by Matt McCall



3 Hot Marijuana Stocks to Buy for 2019 – A Guide for Investors

hot-marijuana-stocks-to-buy-investorplace-moneywire-matt-mccallMarijuana is a growing business in North America. As Canada has fully legalized the substance, and many states within the United States already have legalized it in one way or another. The market is now becoming big enough to become an investment opportunity, and some people need a little guidance to see where their money should go.

In this special report by Matt McCall and his Money Wire weekly newsletter, he talks about an urgent update for turning every $1 into $450 and even upwards of $2,800 in his ‘Royal Gold of Marijuna' video presentation. The slogan tagline says everyone must know this information and get the details before June 27th as it will be too late past this special date. While referencing Tilray's crazy growth, or talking about starting up your own cannabis-focused business, he says these options are not ideal for the average person and involving investing into the red-hot cannabis stock industry.

During his video pitch, he talks about the 1983 to 1992 to present day returns on these big swings that are happening in unfolding markets like medical marijuana and CBD. All of this leads into opting into a possible ‘royalty' business model that is crossing into the cannabis industry. While no reference to the penny pot stock is made, it seems to be what the focus of the offer is about.

Reference to Investment Returns

Reference to Investment Returns from Stanley Dempsey's gold mining operation

Aside from this initial ROI example, Matt McCall goes into Royal Gold (RGLD 297,000% gains), Franco Nevada ( FNV 45,300% gains), Wheaton Precious Metals Group (WPM 1,700% gains) and Sabine Royalty Trust (SBR 10,200 gains).

Marijuana Demand is Set to Explode

Marijuana Demand is Set to Explode, Dwarfing Other Major Commodities Markets

Much like other guides, this e-book offers details that will teach users about the hottest stocks in marijuana that could improve their investment profile. Though the Matt McCall Investment Opportunities guide is usually priced at $4.95, there’s presently a special that allows users to download a copy to their device for free. The price won’t stay that way much longer, and the most recent view of the website shows that 27 copies are still available to download.

Here is how the InvestorPlace website breaks down the Royal Gold of Marijuana membership inclusion list:

BENEFIT #1: The Royal Gold of Marijuana. (Value: $149)

BENEFIT #2: BONUS REPORT The Amazon of Weed. (Value: $149)

BENEFIT #3: BONUS REPORT The Government-Authorized Way to Collect American Marijuana Royalties. (Value: $149)

BENEFIT #4: 12 Monthly Issues of Matt McCall’s Investment Opportunities. (Value: $199)

BENEFIT #5: Urgent position updates: (Value: $49)

BENEFIT #6: Access to the Investment Opportunities Support Team

To learn more, consumers can call InvestorPlace at or visite the website to see the MoneyWire Special report by Matt McCall.

Andrew is a full-time professional writer in Canada with over 8 years of esteemed experience. He is one of the best cannabis health researchers, polished legal investigators and active CBD news reporters we have at TOC. While being featured in hundreds of health, technology, science, and even bitcoin publications; Andrew's now on the frontline of the Canadian cannabis culture and will continue breaking down everything so easily your grandma can understand hemp and CBD.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.